John C. Byrd, MD¹, Jennifer A. Woyach, MD², Richard R. Furman, MD³, Peter Martin, FRCPC, MD, MS³, Susan M. O'Brien⁴, Jennifer R. Brown, MD, PhD⁵, Deborah M. Stephens, DO⁶, Jacqueline C. Barrientos, MD, MS⁷, Piers EM Patten, MB, ChB, FRCP, FRCPath, PhD⁸, Talha Munir, MBBS, MRCP, FRCPath, PhD^9*, Krish Patel, MD^10*, Anna Butturini^11*, Marianne de Borja^12*, Min Hui Wang^11*, Nitin Jain, MD¹³ and William G. Wierda, MD, PhD¹³

¹The Ohio State University Comprehensive Cancer Center, Columbus, OH
²Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY
³Weill Cornell Medicine College, New York Presbyterian Hospital, New York, NY
⁴Chao Family Comprehensive Cancer Center, University of California, Irvine
⁵Dana-Farber Cancer Institute, Boston, MA
⁶University of Utah Huntsman Cancer Institute, Salt Lake City, UT
⁷Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY
⁸King's College Hospital and King's College, London, United Kingdom
⁹St. James’s University Hospital, Leeds, United Kingdom
¹⁰Swedish Cancer Institute, Seattle, WA
¹¹AstraZeneca, South San Francisco, CA
¹²AstraZeneca, Mississauga, Canada
¹³The University of Texas MD Anderson Cancer Center, Houston, TX

Abi Vijenthira, MD^1,2, Aswin Sekar, MD, PhD^3*, Christopher J. Gibson, MD^4,5, Stephen P. Martindale^3*, Rayan Fardoun, BS^3*, Svitlana Tyekucheva, PhD^6*, Yue Ren, MS^7*, Stacey M. Fernandes, BS^3*, Binyamin A. Knisbacher, PhD^8*, Cynthia K. Hahn, MD, PhD^3,8*, Gad Getz, PhD^5,9,10*, Catherine J. Wu, MD^11,12,13, Matthew S. Davids, MD^13,14,15 and Jennifer R. Brown, MD, PhD^13,16

¹Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada
²Department of Medicine, University of Toronto, Toronto, ON, Canada
³Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁴Dana-Farber Cancer Institute, Boston, MA
⁵Department of Medicine, Harvard Medical School, Boston, MA
⁶Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Boston, MA
⁷Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
⁸Broad Institute of MIT and Harvard, Cambridge, MA
⁹Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA
¹⁰Department of Pathology, Massachusetts General Hospital Cancer Center, Boston, MA
¹¹Department of Medical Oncology, Dana-Farber Cancer Institute, Inc, Boston, MA
¹²Department of Medicine, Brigham and Women's Hospital, Boston, MA
¹³Harvard Medical School, Boston, MA
¹⁴Department of Medical Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Ctr, Boston, MA
¹⁵Department of Medicine, Brigham and Women’s Hospital, Boston, MA
¹⁶Department of Medical Oncology, Dana-Farber Cancer Institute, Newton, MA

Christine E. Ryan, MD¹, Jennifer L. Crombie, MD^1*, Svitlana Tyekucheva, PhD^2*, Mikaela M. McDonough, BS^1*, Josie S. Montegaard, NP^1*, Austin I. Kim, MD¹, Jacob D. Soumerai, MD³, Alvaro J. Alencar, MD⁴, Shruti Bhandari, MD^5*, David C. Fisher, MD^1*, Jennifer R. Brown¹ and Matthew S. Davids, MD¹

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
²Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
³Center for Lymphoma, Massachusetts General Hospital, Boston, MA
⁴Miller School of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
⁵Northern Light Cancer Care, Eastern Maine Medical Center, Brewer, ME

Richard R. Furman, MD¹, William G. Wierda, MD, PhD², Anna Schuh, MD, PhD, FRCP, FRCPath³, Piers EM Patten, MB, ChB, FRCP, FRCPath, PhD⁴, Jorge M. Chaves, MD^5*, Jennifer R. Brown, MD, PhD⁶, Talha Munir, MBBS, MRCP, FRCPath, PhD^7*, Peter Martin, FRCPC, MD, MS¹, Farrukh T. Awan, MD⁸, Deborah M. Stephens, DO⁹, Paolo Ghia, MD, PhD¹⁰, Jacqueline C. Barrientos, MD, MS¹¹, Krish Patel, MD¹², Jennifer A. Woyach, MD¹³, Anna Butturini^14*, Marianne de Borja^15*, Min Hui Wang^14*, Susan M. O'Brien¹⁶ and John C. Byrd, MD¹³

¹Weill Cornell Medicine, New York Presbyterian Hospital, New York, NY
²The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Oncology, University of Oxford, Oxford, United Kingdom
⁴King's College Hospital and King's College, London, United Kingdom
⁵Northwest Medical Specialties, Tacoma, WA
⁶Dana-Farber Cancer Institute, Boston, MA
⁷St. James’s University Hospital, Leeds, United Kingdom
⁸University of Texas Southwestern Medical Center, Dallas, TX
⁹University of Utah Huntsman Cancer Institute, Salt Lake City, UT
¹⁰Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milan, Italy
¹¹Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY
¹²Swedish Cancer Institute, Seattle, WA
¹³The Ohio State University Comprehensive Cancer Center, Columbus, OH
¹⁴AstraZeneca, South San Francisco, CA
¹⁵AstraZeneca, Mississauga, Canada
¹⁶Chao Family Comprehensive Cancer Center, University of California, Irvine, CA

Sai Prasad Desikan, MD^1*, Michael J. Keating, MBBS², Alessandra Ferrajoli², Nitin Jain, MD³, Maro Ohanian, DO^4*, Naveen Pemmaraju, MD⁴, Courtney D. DiNardo, MD, MSCE⁴, Marina Konopleva, MD, PhD⁴, Tapan M. Kadia, MD⁴, Susan M. O'Brien⁵, Zeev E. Estrov, MD⁴, Deborah A Thomas, MD⁴, Jan A. Burger, MD, PhD⁴, Philip A. Thompson, MBBS⁴ and William G. Wierda, MD, PhD⁴

¹Leukemia, The University of Texas MD Anderson Cancer Center, Little Rock, AR
²Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
³Department of Leukemia, MD Anderson Cancer Center, Houston, TX
⁴Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵UCI Cancer Center, Orange, CA

Nadine Kutsch, MD^1,2*, Anna Maria Fink, MD^3*, Anno Federhen^4*, Adam Giza^5*, Sandra Robrecht, PhD^5*, Janina Stumpf^3*, Andrea Stoltefuß, MD^6*, Ursula Vehling-Kaiser^7*, Michael Koenigsmann, MD⁸, Eugen Tausch, MD⁹, Christof Schneider, MD^10*, Stephan Stilgenbauer, MD¹¹, Thomas Illmer, MD^12*, Rudolf Schlag^13*, Steffen Dörfel^14*, Tobias Gaska, MD¹⁵, Michael G. Kiehl, MD, PhD¹⁶, Kirsten Fischer, MD^3*, Barbara Eichhorst, MD¹⁷ and Michael Hallek, MD³

¹Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Düsseldorf, German CLL Study Group, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany, Cologne, Germany
²University Hospital of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne, Germany
³Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, Cologne, Germany
⁴epartment I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, Cologne, Germany
⁵Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Düsseldorf, German CLL Study Group, University Hospital Cologne, Cologne, Germany
⁶Evangelisches Krankenhaus Hamm, Hamm, Germany
⁷UBAG MVZ Dr. Vehling-Kaiser GmbH, Landshut, Germany
⁸Onkologisches Ambulanzzentrum Hannover, Hannover, Germany
⁹Department of Internal Medicine III, University of Ulm, Ulm, Baden-Württemberg, Germany
¹⁰Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany
¹¹Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany
¹²BAG Freiberg-Richter, Jacobasch, Wolf, Illmer,, Hematology-Oncology Practice, Dresden, Germany
¹³Hämatologisch-Onkologische Schwerpunktpraxis, Würzburg, Germany
¹⁴Onkozentrum Dresden, Dresden, Germany
¹⁵Hematology und Oncology, Brüderkrankenhaus St. Josef, Paderborn, Germany
¹⁶Department of Internal Medicine, Klinikum Frankfurt (Oder) GmbH, Frankfurt (Oder), Germany
¹⁷Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University of Cologne, Cologne, Germany

Jacqueline F Wang, MD^1*, Steven R Hwang, MD², Yi Jiang, MPH^3*, Xinyue Qi, PhD^3*, Shijia Zhang, MD, PhD⁴, Sameer A. Parikh, MD², Wei Ding, MBBS, PhD², Saad S. Kenderian, MD², Eli Muchtar, MD⁵, Paul J. Hampel, MD², Jose F. Leis, MD, PhD⁶, Javier L Munoz, MD, MBA^6*, Gita Thanarajasingam, MD², Jonas Paludo, MD², David J. Inwards, MD², Grzegorz S. Nowakowski, MD⁷, Stephen M. Ansell, MD, PhD⁷, Thomas M. Habermann, MD², Thomas E. Witzig, MD², Neil E. Kay, MD², Shouhao Zhou, PhD^3* and Yucai Wang, MD, PhD²

¹Department of Medicine, NYU Langone Health, New York, NY
²Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
³Division of Biostatistics and Bioinformatics, Department of Public Health Sciences, Penn State College of Medicine, Hershey, PA
⁴Illinois CancerCare, Peoria, IL
⁵Associate Professor of Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN
⁶Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ
⁷Division of Hematology, Mayo Clinic, Rochester, MN

Meghan C. Thompson, MD¹, Catherine C. Coombs, MD², Lindsey Roeker, MD¹, Jeffrey L. Jensen, MD, PhD^2*, Nirav N. Shah, MD³, Thomas Luo, BS⁴, Krish Patel, MD⁵, Neil Bailey, MSc^5*, Bita Fakhri, MD, MPH⁶, Toby A. Eyre, MBBChir, MRCP^7*, Paola Ghione, MD⁸, Joanna M. Rhodes, MD, MSCE⁹, Andrew D. Zelenetz, MD, PhD¹, Justin Taylor, MD¹⁰, Maria Lia Palomba¹, Kendall Meyer, BA^1*, Danielle Rao, DMD^1*, Yehudit Fox, BS^1*, Julia H. Aronson, MD^1*, Sarah Court, BA^1*, Omar Abdel-Wahab, MD¹ and Anthony R. Mato, MD, MSCE¹

¹Memorial Sloan Kettering Cancer Center, New York, NY
²Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
³Medical College of Wisconsin, Brookfield, WI
⁴Medical College of Wisconsin, Milwaukee, WI
⁵Swedish Cancer Institute, Center for Blood Disorders and Cellular Therapy, Seattle, WA
⁶Hematology, Stanford University, Stanford
⁷Department of Haematology, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, HP11 2TJ, United Kingdom
⁸Roswell Park Comprehensive Cancer Center, New York, NY
⁹Northwell Health Cancer Institute, New Hyde Park, NY
¹⁰University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL

Jiasheng Wang, MD¹, Srilatha Dasari, MD^2*, Michael Daunov, DO¹, Kanithra Sekaran, MD^2*, Yeseong Kim, MD^3* and Brenda W. Cooper, MD⁴

¹Department of Hematology and Oncology, Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH
²Department of Medicine, MetroHealth Medical Center, Cleveland, OH
³Department of Medicine, Temple University School of Medicine, Philadelphia, PA
⁴Adult Hematologic Malignancies & Stem Cell Transplant Section, Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH

Elisavet Vlachonikola^1,2*, Electra Sofou^1,3*, Marina Gerousi^1*, Efthimia Katsika^1,4*, Nikolaos Pechlivanis^1,2*, Georgios Karakatsoulis^1,5*, Maria Dimou⁶, Thomas Chatzikonstantinou^7*, Michail Iskas^8*, Panagiotis Panagiotidis^9*, Ioanna Sakellari^8*, Niki Stavroyianni^10*, Kostas Stamatopoulos¹ and Anastasia Chatzidimitriou^1*

¹Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece
²Department of Genetics, Development and Molecular Biology, Faculty of Biology, Aristotle University of Thessaloniki, Thessaloniki, Greece
³Laboratory of Biological Chemistry, School of Medicine, Aristotle university of Thessaloniki, Thessaloniki, Greece
⁴Department of Molecular Biology & Genetics, Democritus University of Thrace, Alexandroupolis, Greece
⁵Department of Mathematics, School of Sciences, University of Ioannina, Ioannina, Greece
⁶First Propedeutic Department of Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, Greece, Athens, Greece
⁷Hematology Department and HCT Unit, G. Papanikolaou Hospital, Thessaloniki, Greece
⁸Hematology Department and HCT Unit, George Papanikolaou General Hospital, Thessaloniki, Greece
⁹First Propaedeutic Department of Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
¹⁰Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece

Alexander Coltoff, MD^*, Andrew H. Lipsky, MD, Todd L. Rosenblat, MD, MS^*, Jennifer E. Amengual, MD, Mark L Heaney, MD, PhD^*, Joseph G. Jurcic, MD and Nicole Lamanna, MD

Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY

Emily Bryer, DO¹, Shira Paul, MD¹, Jonathan Chen^1*, Christopher Pleyer, MD¹, Adrian Wiestner, MD^1,2 and Clare Sun, MD³

¹Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
²Hematology Branch, National Heart, Lung, and Blood Institute, NIH, NHLBI, Bethesda, MD
³Hematology Branch, National Heart, Lung, and Blood Institute, National Heart, Lung and Blood Institute, Bethesda, MD

Sylvain Choquet, MD^1*, Marine Deslandes^2*, Nahid Macher, MD^2*, Gérard De Pouvourville^3*, Clarisse Marchal^4*, Manon Belhassen^4*, Flore Jacoud^4* and Vincent Levy, MD, PhD^5*

¹La Pitie Salpetriere Hospital, APHP-Sorbonne Universite, Paris, France
²Janssen France, Issy-les-Moulineaux, France
³Economie, ESSEC Business School, Cergy-Pontoise, France
⁴PELyon, Lyon, France
⁵URC/CRC, Hopital Avicenne, AP-HP, Bobigny, France

Ohad Benjamini^1,2*, Tamar Tadmor, MD^3,4*, Abraham Avigdor, MD^1,2, Rotem Gershon^1,2*, Limor Klike^2,5*, Nofar Atari^5*, Bayan Abdelkader^5*, Michal Mandelboim, Phd^2,5* and Galia Rahav, MD^2,6*

¹Hematology Division, Chaim Sheba Medical Center, Tel-Hashomer, Israel
²Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel
³Bnai Zion Medical Center, Haifa, Israel
⁴The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel
⁵Central Virology Laboratory, Public Health Services, Ministry of Health and Sheba Medical Cente, Ramat-Gan, Israel
⁶The Infectious Disease Unit, Chaim Sheba Medical Center, Ramat Gan, Israel

Rahul Mishra, MBBS^1*, Agrima Mian, MBBS, MD², Shiva Jashwanth Gaddam, MD³, Paolo F Caimi, MD¹ and Deepa Jagadeesh, MD¹

¹Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
²Department of Internal Medicine, Cleveland Clinic, Cleveland, OH
³Hematology and Oncology, Louisiana State University Health Sciences Center, Shreveport, Shreveport, LA

Sikander Ailawadhi¹, Ricardo D Parrondo, MD², Aneel Paulus, MD¹, Betsy Laplant, MS^3*, Victoria R. Alegria^4*, Ashley Zimmerman^5*, Dustin Chapin^6*, Taimur Sher, MD², Vivek Roy, MD⁴ and Asher Chanan-Khan, MD⁶

¹Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL
²Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
³Division of Clinical Trials & Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
⁴Mayo Clinic Comprehensive Cancer Center, Jacksonville, FL
⁵Hematology-Oncology, Mayo Clinic, Jacksonville, FL
⁶Mayo Clinic, Jacksonville, FL

Caroline Dartigeas, MD^1*, Loic Ysebaert, MD, PhD^2*, Pierre Feugier, MD, PhD^3,4*, Alain Delmer⁵, Sandrine Dupuis^6*, Marine Deslandes^6*, Marjolein Lahaye^7* and Veronique Leblond, MD, PhD⁸

¹Department of Hematology and Cellular Therapy, CHRU de Tours, Hôpital Bretonneau, Tours, France
²Hematology Department, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
³Hematology Department, University Hospital of Nancy, Vandoeuvre, France
⁴IMoPa, University of Lorraine, Vandoeuvre, France
⁵Department of Hematology, CHU de Reims, Reims, France
⁶Janssen France, Issy-les-Moulineaux, France
⁷Janssen-Cilag BV, Breda, Netherlands
⁸Sorbonne University, Hôpital Pitié Salpêtrière, Paris, France

Christelle Ferra^1*, María José Terol, MD PhD^2*, Juan Marquet Palomanes, MD^3*, Angel Ramírez Payer, MD^4*, Carol Moreno, MD, PhD^5*, Santiago Osorio, MD^6*, Fátima De la Cruz, MD^7*, Jose A. Garcia-Marco⁸, Macarena Ortiz, MD^9*, Eduardo Rios Herranz, MD^10*, Laura Magnano, MD^11*, Sandra Iraheta, MD^12*, Jose Manuel Puerta, MD^13*, Javier de la Serna, MD^14*, Alicia Smucler^15*, Jose Maria Arguiñano, MD^16*, Javier Loscertales^17*, Begoña Muiña, MD^18*, Rubén Fernández, MD^19*, Tomas García, MD, PhD^20*, José A. Márquez, MD^21*, Ana Muntañola Prat, MD^22*, Ernesto Perez Persona^23*, Lucrecia Yáñez, MD, PhD^24*, Manuel Pérez-Encinas, MD^25*, Marcos González Díaz, MD^26*, Gonzalo Caballero, MD^27*, María Angeles Andreu, MD, PhD^28*, Rafael Andreu, MD^29*, Ana Ruiz-Zorrilla, MD^30*, Diana Moreno^30* and Patricia Baltasar, MD^31*

¹Institut Català d´Oncologia-H. Germans Trias i Pujol, Badalona, Spain
²Department of Hematology, Hospital Clínico Universitario de Valencia, INCLIVA, Valencia, Spain
³Hematology Service, Hospital Universitario Ramón y Cajal, Madrid, Spain
⁴Hospital Universitario Central de Asturias, Oviedo, Spain
⁵Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Josep Carreras Leukaemia Research Institute, Barcelona, Spain
⁶Hospital General U. Gregorio Marañón, Madrid, Spain
⁷Hospital Universitario Virgen del Rocío, Sevilla, Spain
⁸Hematology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Majadahonda, Spain
⁹Hospital Regional Universitario Carlos Haya, Málaga, Spain
¹⁰Hospital Universitario Virgen de Valme, Sevilla, Spain
¹¹Hospital Clínic, Universitat de Barcelona, Barcelona, Spain
¹²Hospital Universitario de Canarias, La Laguna, Tenerife, Spain
¹³Hospital Universitario Virgen de las Nieves, Granada, Spain
¹⁴Hospital Universitario 12 de Octubre, Madrid, Spain
¹⁵Hospital del Bierzo, León, Spain
¹⁶Complejo Hospitalario de Navarra, Pamplona, Spain
¹⁷University Hospital of La Princesa, Madrid, Spain
¹⁸Hospital General Universitario Rafael Méndez, Lorca, Spain
¹⁹Hospital Universitario de Cabueñes, Gijón, Spain
²⁰Hospital Arnau de Vilanova, Lleida, Spain
²¹Hospital Universitario de Basurto, Bilbao, Spain
²²Hospital Mutua Terrassa, Terrassa, Barcelona, Spain
²³Bioaraba [Onco-Hematology Group]. Osakidetza [OSI Araba], Hospital Universitario de Álava [Department of Hematology], Vitoria-Gasteiz, Spain
²⁴Hematology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain
²⁵H Clínico U. Santiago de Compostela, A Coruña, Spain
²⁶Hospital Universitario de Salamanca, Salamanca, Spain
²⁷Hematology, Hospital Universitario Miguel Servet, Zaragoza, Spain
²⁸Hospital Universitario de Móstoles, Madrid, MADRID, Spain
²⁹Hospital Universitario La Fe, VALENCIA, Spain
³⁰Departamento Médico Abbvie Spain, S.L.U., Madrid, Spain
³¹Hospital Universitario La Paz, Madrid, Spain

Ashley Whitechurch^1*, Rory Bennett^2*, Shafqat Inam^3*, Benjamin Hartog^1*, Rebecca Blackwood^1*, Shevon Fernando^3*, Felanita Hutani^3*, Hadley Bortz, BPharm, GradCert PharmPrac, MClinPharm, MSHP^3*, Mitchel Lincoln^3*, Dennis Carney^4,5*, Andrew W Roberts, MBBS, PhD^6,7, Mary Ann Anderson, MBBS, PhD^8,9, Constantine S. Tam, MD, MBBS^3,10 and John F. Seymour, MBBS, PhD, FRACP^2,4,11

¹Peter MacCallum Cancer Centre, Melbourne, Australia
²Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
³Alfred Hospital, Melbourne, Australia
⁴University of Melbourne, Melbourne, Australia
⁵Peter MacCallum Cancer Centre & Royal Melbourne Hospital, Melbourne, Australia
⁶The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia
⁷Department of Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC, Australia
⁸Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia
⁹Blood Cells and Blood Cancers, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia
¹⁰Monash University, Melbourne, Australia
¹¹Royal Melbourne Hospital, Parkville, VIC, Australia

Stefano Molica, MD^1,2, David Allsup^3*, Aaron Polliack, MD^4* and Diana Giannarelli, PhD^5*

¹Department Hematology, Hull University Teaching Hospitals NHS Trust, Hull, UK, Department Hematology, Hull University Teaching Hospitals NHS Trust, Hull, UK, Catanzaro, Italy
²Department Hematology, Hull University Teaching Hospitals NHS Trust, Hull, UK, Department Hematology, Hull University Teaching Hospitals NHS Trust, Hull, UK, Hull, United Kingdom
³Centre for Atherothrombosis and Metabolic Disease, Hull York Medical School, Hull, ENG, United Kingdom
⁴Hadassah University Hospital and Hebrew University Medical School, Jerusalem, Israel
⁵Biostatistics Unit, Scientific Directorate, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy., Biostatistics Unit, Scientific Directorate, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy., Rome, Italy

Kana Tai Lucero^1,2*, Christopher R. Frei^1,2,3*, Kellie J. Ryan, MPH^4*, Obiageri O. Obodozie-Ofoegbu^3*, Amanda M. Moore, PharmD^3*, Chengwen Teng, PharmD, PhD^3,5*, Xavier Jones^1,3* and Zohra Nooruddin, MD^1,2

¹South Texas Veterans Health Care System, San Antonio, TX
²Long School of Medicine, University of Texas Health San Antonio, San Antonio, TX
³College of Pharmacy, The University of Texas at Austin, San Antonio, TX
⁴Global Medical Affairs, AstraZeneca Pharmaceuticals, Gaithersburg, MD
⁵Department of Clinical Pharmacy and Outcomes Sciences, College of Pharmacy, The University of South Carolina, Columbia, SC